Global Ivonescimab Injection Market Growth 2024-2030

November 2024 | 79 pages | ID: G46681382F75EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Ivonescimab Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Ivonescimab Injection Industry Forecast” looks at past sales and reviews total world Ivonescimab Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Ivonescimab Injection sales for 2024 through 2030. With Ivonescimab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ivonescimab Injection industry.

This Insight Report provides a comprehensive analysis of the global Ivonescimab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ivonescimab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ivonescimab Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ivonescimab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ivonescimab Injection.

United States market for Ivonescimab Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Ivonescimab Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Ivonescimab Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Ivonescimab Injection players cover Akeso Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Ivonescimab Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 100 mg (10mL)/Bottle
• Other

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Akeso Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ivonescimab Injection market?

What factors are driving Ivonescimab Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ivonescimab Injection market opportunities vary by end market size?

How does Ivonescimab Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ivonescimab Injection Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Ivonescimab Injection by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Ivonescimab Injection by Country/Region, 2019, 2023 & 2030
2.2 Ivonescimab Injection Segment by Type
  2.2.1 100 mg (10mL)/Bottle
  2.2.2 Other
2.3 Ivonescimab Injection Sales by Type
  2.3.1 Global Ivonescimab Injection Sales Market Share by Type (2019-2024)
  2.3.2 Global Ivonescimab Injection Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Ivonescimab Injection Sale Price by Type (2019-2024)
2.4 Ivonescimab Injection Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 Ivonescimab Injection Sales by Application
  2.5.1 Global Ivonescimab Injection Sale Market Share by Application (2019-2024)
  2.5.2 Global Ivonescimab Injection Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Ivonescimab Injection Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Ivonescimab Injection Breakdown Data by Company
  3.1.1 Global Ivonescimab Injection Annual Sales by Company (2019-2024)
  3.1.2 Global Ivonescimab Injection Sales Market Share by Company (2019-2024)
3.2 Global Ivonescimab Injection Annual Revenue by Company (2019-2024)
  3.2.1 Global Ivonescimab Injection Revenue by Company (2019-2024)
  3.2.2 Global Ivonescimab Injection Revenue Market Share by Company (2019-2024)
3.3 Global Ivonescimab Injection Sale Price by Company
3.4 Key Manufacturers Ivonescimab Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Ivonescimab Injection Product Location Distribution
  3.4.2 Players Ivonescimab Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR IVONESCIMAB INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Ivonescimab Injection Market Size by Geographic Region (2019-2024)
  4.1.1 Global Ivonescimab Injection Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Ivonescimab Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Ivonescimab Injection Market Size by Country/Region (2019-2024)
  4.2.1 Global Ivonescimab Injection Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Ivonescimab Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ivonescimab Injection Sales Growth
4.4 APAC Ivonescimab Injection Sales Growth
4.5 Europe Ivonescimab Injection Sales Growth
4.6 Middle East & Africa Ivonescimab Injection Sales Growth

5 AMERICAS

5.1 Americas Ivonescimab Injection Sales by Country
  5.1.1 Americas Ivonescimab Injection Sales by Country (2019-2024)
  5.1.2 Americas Ivonescimab Injection Revenue by Country (2019-2024)
5.2 Americas Ivonescimab Injection Sales by Type (2019-2024)
5.3 Americas Ivonescimab Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ivonescimab Injection Sales by Region
  6.1.1 APAC Ivonescimab Injection Sales by Region (2019-2024)
  6.1.2 APAC Ivonescimab Injection Revenue by Region (2019-2024)
6.2 APAC Ivonescimab Injection Sales by Type (2019-2024)
6.3 APAC Ivonescimab Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Ivonescimab Injection by Country
  7.1.1 Europe Ivonescimab Injection Sales by Country (2019-2024)
  7.1.2 Europe Ivonescimab Injection Revenue by Country (2019-2024)
7.2 Europe Ivonescimab Injection Sales by Type (2019-2024)
7.3 Europe Ivonescimab Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ivonescimab Injection by Country
  8.1.1 Middle East & Africa Ivonescimab Injection Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Ivonescimab Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Ivonescimab Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Ivonescimab Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ivonescimab Injection
10.3 Manufacturing Process Analysis of Ivonescimab Injection
10.4 Industry Chain Structure of Ivonescimab Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Ivonescimab Injection Distributors
11.3 Ivonescimab Injection Customer

12 WORLD FORECAST REVIEW FOR IVONESCIMAB INJECTION BY GEOGRAPHIC REGION

12.1 Global Ivonescimab Injection Market Size Forecast by Region
  12.1.1 Global Ivonescimab Injection Forecast by Region (2025-2030)
  12.1.2 Global Ivonescimab Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Ivonescimab Injection Forecast by Type (2025-2030)
12.7 Global Ivonescimab Injection Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Akeso Inc
  13.1.1 Akeso Inc Company Information
  13.1.2 Akeso Inc Ivonescimab Injection Product Portfolios and Specifications
  13.1.3 Akeso Inc Ivonescimab Injection Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Akeso Inc Main Business Overview
  13.1.5 Akeso Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Ivonescimab Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Ivonescimab Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 100 mg (10mL)/Bottle
Table 4. Major Players of Other
Table 5. Global Ivonescimab Injection Sales byType (2019-2024) & (K Units)
Table 6. Global Ivonescimab Injection Sales Market Share byType (2019-2024)
Table 7. Global Ivonescimab Injection Revenue byType (2019-2024) & ($ million)
Table 8. Global Ivonescimab Injection Revenue Market Share byType (2019-2024)
Table 9. Global Ivonescimab Injection Sale Price byType (2019-2024) & (US$/Unit)
Table 10. Global Ivonescimab Injection Sale by Application (2019-2024) & (K Units)
Table 11. Global Ivonescimab Injection Sale Market Share by Application (2019-2024)
Table 12. Global Ivonescimab Injection Revenue by Application (2019-2024) & ($ million)
Table 13. Global Ivonescimab Injection Revenue Market Share by Application (2019-2024)
Table 14. Global Ivonescimab Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Ivonescimab Injection Sales by Company (2019-2024) & (K Units)
Table 16. Global Ivonescimab Injection Sales Market Share by Company (2019-2024)
Table 17. Global Ivonescimab Injection Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Ivonescimab Injection Revenue Market Share by Company (2019-2024)
Table 19. Global Ivonescimab Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Ivonescimab Injection Producing Area Distribution and Sales Area
Table 21. Players Ivonescimab Injection Products Offered
Table 22. Ivonescimab Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Ivonescimab Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Ivonescimab Injection Sales Market Share Geographic Region (2019-2024)
Table 27. Global Ivonescimab Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Ivonescimab Injection Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Ivonescimab Injection Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Ivonescimab Injection Sales Market Share by Country/Region (2019-2024)
Table 31. Global Ivonescimab Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Ivonescimab Injection Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Ivonescimab Injection Sales by Country (2019-2024) & (K Units)
Table 34. Americas Ivonescimab Injection Sales Market Share by Country (2019-2024)
Table 35. Americas Ivonescimab Injection Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Ivonescimab Injection Sales byType (2019-2024) & (K Units)
Table 37. Americas Ivonescimab Injection Sales by Application (2019-2024) & (K Units)
Table 38. APAC Ivonescimab Injection Sales by Region (2019-2024) & (K Units)
Table 39. APAC Ivonescimab Injection Sales Market Share by Region (2019-2024)
Table 40. APAC Ivonescimab Injection Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Ivonescimab Injection Sales byType (2019-2024) & (K Units)
Table 42. APAC Ivonescimab Injection Sales by Application (2019-2024) & (K Units)
Table 43. Europe Ivonescimab Injection Sales by Country (2019-2024) & (K Units)
Table 44. Europe Ivonescimab Injection Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Ivonescimab Injection Sales byType (2019-2024) & (K Units)
Table 46. Europe Ivonescimab Injection Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Ivonescimab Injection Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Ivonescimab Injection Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Ivonescimab Injection Sales byType (2019-2024) & (K Units)
Table 50. Middle East & Africa Ivonescimab Injection Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Ivonescimab Injection
Table 52. Key Market Challenges & Risks of Ivonescimab Injection
Table 53. Key IndustryTrends of Ivonescimab Injection
Table 54. Ivonescimab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Ivonescimab Injection Distributors List
Table 57. Ivonescimab Injection Customer List
Table 58. Global Ivonescimab Injection SalesForecast by Region (2025-2030) & (K Units)
Table 59. Global Ivonescimab Injection RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. Americas Ivonescimab Injection SalesForecast by Country (2025-2030) & (K Units)
Table 61. Americas Ivonescimab Injection Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APAC Ivonescimab Injection SalesForecast by Region (2025-2030) & (K Units)
Table 63. APAC Ivonescimab Injection Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Europe Ivonescimab Injection SalesForecast by Country (2025-2030) & (K Units)
Table 65. Europe Ivonescimab Injection RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Ivonescimab Injection SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Ivonescimab Injection RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Global Ivonescimab Injection SalesForecast byType (2025-2030) & (K Units)
Table 69. Global Ivonescimab Injection RevenueForecast byType (2025-2030) & ($ millions)
Table 70. Global Ivonescimab Injection SalesForecast by Application (2025-2030) & (K Units)
Table 71. Global Ivonescimab Injection RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Akeso Inc Basic Information, Ivonescimab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Akeso Inc Ivonescimab Injection Product Portfolios and Specifications
Table 74. Akeso Inc Ivonescimab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Akeso Inc Main Business
Table 76. Akeso Inc Latest Developments



LIST OFFIGURES

Figure 1. Picture of Ivonescimab Injection
Figure 2. Ivonescimab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ivonescimab Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Ivonescimab Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Ivonescimab Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Ivonescimab Injection Sales Market Share by Country/Region (2023)
Figure 10. Ivonescimab Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 100 mg (10mL)/Bottle
Figure 12. Product Picture of Other
Figure 13. Global Ivonescimab Injection Sales Market Share byType in 2023
Figure 14. Global Ivonescimab Injection Revenue Market Share byType (2019-2024)
Figure 15. Ivonescimab Injection Consumed in Hospital
Figure 16. Global Ivonescimab Injection Market: Hospital (2019-2024) & (K Units)
Figure 17. Ivonescimab Injection Consumed in Clinic
Figure 18. Global Ivonescimab Injection Market: Clinic (2019-2024) & (K Units)
Figure 19. Ivonescimab Injection Consumed in Other
Figure 20. Global Ivonescimab Injection Market: Other (2019-2024) & (K Units)
Figure 21. Global Ivonescimab Injection Sale Market Share by Application (2023)
Figure 22. Global Ivonescimab Injection Revenue Market Share by Application in 2023
Figure 23. Ivonescimab Injection Sales by Company in 2023 (K Units)
Figure 24. Global Ivonescimab Injection Sales Market Share by Company in 2023
Figure 25. Ivonescimab Injection Revenue by Company in 2023 ($ millions)
Figure 26. Global Ivonescimab Injection Revenue Market Share by Company in 2023
Figure 27. Global Ivonescimab Injection Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Ivonescimab Injection Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Ivonescimab Injection Sales 2019-2024 (K Units)
Figure 30. Americas Ivonescimab Injection Revenue 2019-2024 ($ millions)
Figure 31. APAC Ivonescimab Injection Sales 2019-2024 (K Units)
Figure 32. APAC Ivonescimab Injection Revenue 2019-2024 ($ millions)
Figure 33. Europe Ivonescimab Injection Sales 2019-2024 (K Units)
Figure 34. Europe Ivonescimab Injection Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Ivonescimab Injection Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Ivonescimab Injection Revenue 2019-2024 ($ millions)
Figure 37. Americas Ivonescimab Injection Sales Market Share by Country in 2023
Figure 38. Americas Ivonescimab Injection Revenue Market Share by Country (2019-2024)
Figure 39. Americas Ivonescimab Injection Sales Market Share byType (2019-2024)
Figure 40. Americas Ivonescimab Injection Sales Market Share by Application (2019-2024)
Figure 41. United States Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Ivonescimab Injection Sales Market Share by Region in 2023
Figure 46. APAC Ivonescimab Injection Revenue Market Share by Region (2019-2024)
Figure 47. APAC Ivonescimab Injection Sales Market Share byType (2019-2024)
Figure 48. APAC Ivonescimab Injection Sales Market Share by Application (2019-2024)
Figure 49. China Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. India Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. ChinaTaiwan Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Ivonescimab Injection Sales Market Share by Country in 2023
Figure 57. Europe Ivonescimab Injection Revenue Market Share by Country (2019-2024)
Figure 58. Europe Ivonescimab Injection Sales Market Share byType (2019-2024)
Figure 59. Europe Ivonescimab Injection Sales Market Share by Application (2019-2024)
Figure 60. Germany Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 61.France Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Ivonescimab Injection Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Ivonescimab Injection Sales Market Share byType (2019-2024)
Figure 67. Middle East & Africa Ivonescimab Injection Sales Market Share by Application (2019-2024)
Figure 68. Egypt Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 71.Turkey Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Ivonescimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Ivonescimab Injection in 2023
Figure 74. Manufacturing Process Analysis of Ivonescimab Injection
Figure 75. Industry Chain Structure of Ivonescimab Injection
Figure 76. Channels of Distribution
Figure 77. Global Ivonescimab Injection Sales MarketForecast by Region (2025-2030)
Figure 78. Global Ivonescimab Injection Revenue Market ShareForecast by Region (2025-2030)
Figure 79. Global Ivonescimab Injection Sales Market ShareForecast byType (2025-2030)
Figure 80. Global Ivonescimab Injection Revenue Market ShareForecast byType (2025-2030)
Figure 81. Global Ivonescimab Injection Sales Market ShareForecast by Application (2025-2030)
Figure 82. Global Ivonescimab Injection Revenue Market ShareForecast by Application (2025-2030)